Personalized medicine requires the integration of information from many imaging modalities. UPMC Hillman Cancer Center’s In Vivo Imaging Facility (IVIF) provides unique state-of-the-art resources, both clinical and preclinical, including simultaneous MR/PET, ultra high-field magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT) and optical (bioluminescence and fluorescence) and ultrasound small animal imaging. These modalities are supported by in-house contrast agent development (MR, optical and PET).
The goals of the facility include:
- Facilitating protocol development for cancer detection, diagnosis and staging
- Providing methods for clinical assessment of early therapeutic response
- Providing preclinical assessment of biomarker expression throughout cancer treatment
Click below to learn more about our services and modalities.
